The CEO change is a routine succession with an experienced external hire; the stock is unlikely to react materially. Monitor Q3 2026 earnings release on November 4, 2026 for any deviation from reaffirmed guidance.
Price Chart
Executive Summary
Avient appointed Mike Frank as CEO, replacing Dr. Ashish Khandpur, and reaffirmed its full-year and Q3 2026 financial guidance. The CEO transition is a routine leadership change with no material financial impact, and the guidance reaffirmation provides no new information for traders.
Key Facts
- Mike Frank appointed President and CEO effective October 7, 2026, succeeding Dr. Ashish Khandpur who remains in an advisory role through year-end.
- Richard H. Fearon appointed Non-Executive Chairman of the Board.
- Company reaffirmed full year and Q3 2026 financial guidance previously provided on August 6, 2026.
- Mr. Frank receives base salary of $1,222,000/year, sign-on cash of $1,600,000, RSUs valued at ~$5,000,000, and cash-settled PUs with target value of ~$11,400,000.
- Dr. Khandpur is entitled to severance per the Executive Severance Plan, including two years salary continuation and prorated 2026 LTI awards.
Financial Impact
No new financial data disclosed; guidance reaffirmed at prior levels (FY2026 adjusted EPS $2.93-$3.17, adjusted EBITDA $555-$585M).
Risk Factors
- Execution risk under new CEO Mike Frank, who comes from agricultural chemicals (UPL, Nutrien, Monsanto) rather than specialty materials.
- Potential for guidance revision at Q3 earnings if macro conditions (tariffs, raw material costs) deteriorate.
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-418501 |
| Document: d158162dex991.htm | 0001193125-26-418501 |
| Document: 0001193125-26-418501-index-headers.html | 0001193125-26-418501 |
| Document: 0001193125-26-418501-index.html | 0001193125-26-418501 |
| Document: 0001193125-26-418501.txt | 0001193125-26-418501 |
| 8-K Data (Synthetic) | 0001193125-26-418501 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 14d ago | 3 | $38.85 | awaiting T+60 | — | $42.43 (+9.21%) |
Oct 9, 2026 18d ago | 8-K | $37.79 | awaiting T+60 | — | $42.43 (+12.28%) |
Oct 1, 2026 26d ago | Press Release | $41.17 | awaiting T+60 | — | $42.43 (+3.06%) |
May 7, 2026 24w ago | 8-K | $36.52 $37.39 | ▲ +2.38% | ▼ −1.45% | $42.43 (+16.18%) |
Apr 27, 2026 26w ago | 8-K | $37.16 $37.36 | ▲ +0.54% | ▼ −4.24% | $42.43 (+14.18%) |
Mar 27, 2026 30w ago | DEFA14A | $35.55 $36.57 | ▲ +2.87% | ▼ −13.20% | $42.43 (+19.35%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers